Measurement of total-body calcium (TBCa) is important in the study of several medical conditions. Neutron activation analysis (NAA) is sufficiently precise for serial measurements, but in order to provide single, absolute determinations of TBCa, it requires a correction for body habitus. A method is described for the absolute determination of TBCa by comparing the total-body chlorine, obtained by NAA, with that obtained by stable bromine dilution. The method is applied to a group of thirty patients who had been treated for chronic renal failure, and significant differences are found between measured values of TBCa and those predicted for 'normal' healthy subjects. The overall experimental error in the absolute determination of TBCa is estimated to be 8%, for a dose equivalent of 3.1 mSv (based on skin dose, and a quality factor of 10 for neutrons).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1088/0967-3334/15/1/006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Somatostatin Receptor Imaging in the Diagnosis and Management of Parathyroid Neuroendocrine Neoplasia.
Diagnostics (Basel)
December 2024
Almazov National Medical Research Centre, 2 Akkuratova Street, Saint Petersburg 197341, Russia.
Background: Parathyroid tumors are classified as parathyroid neuroendocrine neoplasia (NEN) by the IARC-WHO classification. These tumors can occur with NENs from other sites, which often require total-body [68Ga]-DOTA-peptides PET/CT. This study aimed to assess the utility of [68Ga]-DOTA-peptide PET/CT in imaging parathyroid NENs and to evaluate the underlying mechanisms.
View Article and Find Full Text PDFBone biochemical markers, bone mineral density, and the risk of osteonecrosis of the femoral head: a Mendelian randomization study.
BMC Musculoskelet Disord
December 2024
First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, China.
Background: Alterations in bone metabolism may play a significant role in the early stages of femoral head necrosis, yet the causal relationship remains unclear. This study utilizes a two-sample Mendelian randomization (MR) approach to explore the genetic causal links between biochemical markers of bone metabolism, bone mineral density, and the risk of femoral head necrosis.
Methods: This study utilizes publicly available genome-wide association study (GWAS) datasets, with exposure factors including biochemical bone markers (25OHD, calcium, and alkaline phosphatase) and bone mineral density (measured at the lumbar spine, heel, femoral neck, and total body).
Exploring the depuration of metals in the green shore crab (Carcinus maenas): Studies with radiolabelled calcium, zinc, and nickel.
Sci Total Environ
December 2024
Bamfield Marine Science Centre, Bamfield, British Columbia V0R 1B0, Canada; University of British Columbia, Department of Zoology, Vancouver, BC V6T 1Z4, Canada; McMaster University, Dept. of Biology, Hamilton, Ontario L8S 4K1, Canada.
The depuration of newly accumulated metal from the crab Carcinus maenas (inter-moult stage) was studied, with a particular focus on the carapace, in light of recent findings that it is a major site for direct uptake and incorporation of Ca, Zn, and Ni from the external sea water. Crabs were exposed for 24 h to calcium ([Ca] = 389 mg L or 9.7 mmol L), zinc ([Zn] = 82 μg L or 1.
View Article and Find Full Text PDFBeneficial Effects of a Freeze-Dried Kale Bar on Type 2 Diabetes Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
Nutrients
October 2024
Department of Clinical Medicine, Aarhus University, Aarhus University Hospital, 8200 Aarhus N, Denmark.
Background/objectives: Type 2 diabetes (T2D) is one of the most common global diseases, with an ever-growing need for prevention and treatment solutions. Kale ( L. var.
View Article and Find Full Text PDFZoledronate Therapy in Osteogenesis Imperfecta: Perspectives in Indonesia Tertiary Hospital.
J Bone Metab
November 2024
Department of Orthopaedics, Leiden University Medical Center, Leiden, Netherlands.
Background: Osteogenesis imperfecta (OI) is a rare disease with an estimated incidence of between 1/25,000 and 1/10,000 globally. The main treatment for OI is the administration of bisphosphonate drugs. Research on clinical, radiographic, and biochemical markers to monitor patients with OI treated with zoledronate can be challenging in countries in which patients have limited national health insurance.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!